Physician profile
Denisha Lang
NPI 1043659352
$1,612.35
in general payments reported to CMS, 2019-2025
11 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $745 · 2022: $391 · 2023: $35.68 · 2024: $139 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.22 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.47 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $214.77 | 2021-2023 | Xarelto |
| Abbott Laboratories | $172.62 | 2021 | |
| Heartflow, INC. | $163.05 | 2025 | |
| Inspire Medical Systems, INC. | $138.95 | 2025 | Inspire |
| Novo Nordisk INC | $122.97 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $120.06 | 2024 | Wainua |
| Novartis Pharmaceuticals Corporation | $100.84 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $100.10 | 2021-2024 | Definity |
| Amgen INC. | $16.86 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denisha Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.